Skip to main content
Log in

The role of percutaneous fine needle aspiration biopsy in the management of small renal masses without chance of nephron-sparing surgery

  • Urology - Original Paper
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Purpose

We seek to confirm the safety and efficacy of percutaneous fine needle aspiration biopsy (FNAB) for small renal masses (SRMs) without chance of nephron-sparing surgery (NSS).

Methods

Between 2015 and 2018, 169 consecutive patients with SRMs treated in two medical centers were enrolled in the study retrospectively. All patients were evaluated to be candidates of radical nephrectomy (RN) at the initial evaluation preoperatively and they would receive the second evaluation in operation to decide the ultimate surgical regimen. Patients were divided into two groups according to FNAB.

Results

169 patients met inclusion criteria were enrolled in the finial study. The median follow-up of was 35 months (ranges from 23 to 49 months) from the first diagnosis. 83 patients received FNAB before surgery, and the other 86 patients underwent surgery immediately. The initial success rate of FNAB was 91.6% (76/83) and the rate of accuracy in identifying malignancies was 100%. 15 (18.1%) of 83 patients developed different levels of complications. 15 (18.1%) were diagnosed as benign tumors by FNAB. The initial success rate was just 50% for cystic SRMs. Complicated cystic SRMs account for 5.9% of all with a 50% benignity rate. The FNAB group had a significant lower ratio of RN than non-FNAB group (74.7% vs. 93%, p = 0.001, Pearson Chi-square test).

Conclusion

FNAB is safe and effective for SRMs without chance of NSS, and it could significantly reduce unnecessary RN.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig.1

Similar content being viewed by others

References

  1. Kane CJ, Mallin K, Ritchey J, Cooperberg MR, Carroll PR (2008) Renal cell cancer stage migration: analysis of the national cancer data base. Cancer 113(1):78–83. https://doi.org/10.1002/cncr.23518

    Article  PubMed  Google Scholar 

  2. Hollingsworth JM, Miller DC, Daignault S, Hollenbeck BK (2006) Rising incidence of small renal masses: a need to reassess treatment effect. J Natl Cancer Inst 98(18):1331–1334. https://doi.org/10.1093/jnci/djj362

    Article  PubMed  Google Scholar 

  3. Ljungberg B, Cowan NC, Hanbury DC, Hora M, Kuczyk MA, Merseburger AS, Patard JJ, Mulders PF, Sinescu IC, European association of urology guideline G (2010) EAU guidelines on renal cell carcinoma: the 2010 update. Eur Urol 58(3):398–406. https://doi.org/10.1016/j.eururo.2010.06.032

    Article  PubMed  Google Scholar 

  4. Kutikov A, Uzzo RG (2009) The R.E.N.A.L. nephrometry score: a comprehensive standardized system for quantitating renal tumor size, location and depth. J Urol 182(3):844–853. https://doi.org/10.1016/j.juro.2009.05.035

    Article  PubMed  Google Scholar 

  5. Canter D, Kutikov A, Manley B, Egleston B, Simhan J, Smaldone M, Teper E, Viterbo R, Chen DY, Greenberg RE, Uzzo RG (2011) Utility of the R.E.N.A.L. nephrometry scoring system in objectifying treatment decision-making of the enhancing renal mass. Urology 78(5):1089–1094. https://doi.org/10.1016/j.urology.2011.04.035

    Article  PubMed  PubMed Central  Google Scholar 

  6. Johnson DC, Vukina J, Smith AB, Meyer AM, Wheeler SB, Kuo TM, Tan HJ, Woods ME, Raynor MC, Wallen EM, Pruthi RS, Nielsen ME (2015) Preoperatively misclassified, surgically removed benign renal masses: a systematic review of surgical series and United States population level burden estimate. J Urol 193(1):30–35. https://doi.org/10.1016/j.juro.2014.07.102

    Article  PubMed  Google Scholar 

  7. Shah PH, Alom MA, Leibovich BC, Thompson RH, Uzzo RG, Kavoussi LR, Richstone L, Bhindi B, Habermann EB, Joshi V, Boorjian SA (2018) The temporal association of robotic surgical diffusion with overtreatment of the small renal mass. J Urol 200(5):981–988. https://doi.org/10.1016/j.juro.2018.05.081

    Article  PubMed  Google Scholar 

  8. Jeon HG, Seo SI, Jeong BC, Jeon SS, Lee HM, Choi HY, Song C, Hong JH, Kim CS, Ahn H, Jeong IG (2016) Percutaneous kidney biopsy for a small renal mass: a critical appraisal of results. J Urol 195(3):568–573. https://doi.org/10.1016/j.juro.2015.09.073

    Article  PubMed  Google Scholar 

  9. Azawi NH, Tolouee SA, Madsen M, Berg KD, Dahl C, Fode M (2018) Core needle biopsy clarify the histology of the small renal masses and may prevent overtreatment. Int Urol Nephrol 50(7):1205–1209. https://doi.org/10.1007/s11255-018-1885-y

    Article  CAS  PubMed  Google Scholar 

  10. Seager MJ, Patel U, Anderson CJ, Gonsalves M (2018) Image-guided biopsy of small (</=4 cm) renal masses: the effect of size and anatomical location on biopsy success rate and complications. Br J Radiol 91(1085):20170666. https://doi.org/10.1259/bjr.20170666

    Article  PubMed  PubMed Central  Google Scholar 

  11. Corcoran AT, Russo P, Lowrance WT, Asnis-Alibozek A, Libertino JA, Pryma DA, Divgi CR, Uzzo RG (2013) A review of contemporary data on surgically resected renal masses–benign or malignant? Urology 81(4):707–713. https://doi.org/10.1016/j.urology.2013.01.009

    Article  PubMed  Google Scholar 

  12. Schlomer B, Figenshau RS, Yan Y, Venkatesh R, Bhayani SB (2006) Pathological features of renal neoplasms classified by size and symptomatology. J Urol 176(4Pt1):1317–1320. https://doi.org/10.1016/j.juro.2006.06.005(discussion 1320)

    Article  PubMed  Google Scholar 

  13. Patel HD, Johnson MH, Pierorazio PM, Sozio SM, Sharma R, Iyoha E, Bass EB, Allaf ME (2016) Diagnostic accuracy and risks of biopsy in the diagnosis of a renal mass suspicious for localized renal cell carcinoma: systematic review of the literature. J Urol 195(5):1340–1347. https://doi.org/10.1016/j.juro.2015.11.029

    Article  PubMed  PubMed Central  Google Scholar 

  14. Mehrazin R, Smaldone MC, Kutikov A, Li T, Tomaszewski JJ, Canter DJ, Viterbo R, Greenberg RE, Chen DY, Uzzo RG (2014) Growth kinetics and short-term outcomes of cT1b and cT2 renal masses under active surveillance. J Urol 192(3):659–664. https://doi.org/10.1016/j.juro.2014.03.038

    Article  PubMed  PubMed Central  Google Scholar 

  15. Kunkle DA, Crispen PL, Chen DY, Greenberg RE, Uzzo RG (2007) Enhancing renal masses with zero net growth during active surveillance. J Urol 177(3):849–853. https://doi.org/10.1016/j.juro.2006.10.073(discussion 853-844)

    Article  PubMed  Google Scholar 

  16. Jewett MA, Mattar K, Basiuk J, Morash CG, Pautler SE, Siemens DR, Tanguay S, Rendon RA, Gleave ME, Drachenberg DE, Chow R, Chung H, Chin JL, Fleshner NE, Evans AJ, Gallie BL, Haider MA, Kachura JR, Kurban G, Fernandes K, Finelli A (2011) Active surveillance of small renal masses: progression patterns of early stage kidney cancer. Eur Urol 60(1):39–44. https://doi.org/10.1016/j.eururo.2011.03.030

    Article  PubMed  Google Scholar 

  17. Paterson C, Yew-Fung C, Sweeney C, Szewczyk-Bieda M, Lang S, Nabi G (2017) Predictors of growth kinetics and outcomes in small renal masses (SRM </=4 cm in size): tayside active surveillance cohort (TASC) study European journal of surgical oncology. J Eur Soc Surg Oncol Br Assoc Surg Oncol 43(8):1589–1597. https://doi.org/10.1016/j.ejso.2017.03.006

    Article  CAS  Google Scholar 

  18. Patel HD, Riffon MF, Joice GA, Johnson MH, Chang P, Wagner AA, McKiernan JM, Trock BJ, Allaf ME, Pierorazio PM (2016) A prospective, comparative study of quality of life among patients with small renal masses choosing active surveillance and primary intervention. J Urol 196(5):1356–1362. https://doi.org/10.1016/j.juro.2016.04.073

    Article  PubMed  Google Scholar 

  19. Smaldone MC, Kutikov A, Egleston BL, Canter DJ, Viterbo R, Chen DY, Jewett MA, Greenberg RE, Uzzo RG (2012) Small renal masses progressing to metastases under active surveillance: a systematic review and pooled analysis. Cancer 118(4):997–1006. https://doi.org/10.1002/cncr.26369

    Article  PubMed  Google Scholar 

  20. Chawla SN, Crispen PL, Hanlon AL, Greenberg RE, Chen DY, Uzzo RG (2006) The natural history of observed enhancing renal masses: meta-analysis and review of the world literature. J Urol 175(2):425–431. https://doi.org/10.1016/S0022-5347(05)00148-5

    Article  PubMed  Google Scholar 

  21. Pierorazio PM, Johnson MH, Ball MW, Gorin MA, Trock BJ, Chang P, Wagner AA, McKiernan JM, Allaf ME (2015) Five-year analysis of a multi-institutional prospective clinical trial of delayed intervention and surveillance for small renal masses: the DISSRM registry. Eur Urol 68(3):408–415. https://doi.org/10.1016/j.eururo.2015.02.001

    Article  PubMed  Google Scholar 

  22. Volpe A, Panzarella T, Rendon RA, Haider MA, Kondylis FI, Jewett MA (2004) The natural history of incidentally detected small renal masses. Cancer 100(4):738–745. https://doi.org/10.1002/cncr.20025

    Article  PubMed  Google Scholar 

  23. Richard PO, Jewett MA, Bhatt JR, Kachura JR, Evans AJ, Zlotta AR, Hermanns T, Juvet T, Finelli A (2015) Renal tumor biopsy for small renal masses: a single-center 13-year experience. Eur Urol 68(6):1007–1013. https://doi.org/10.1016/j.eururo.2015.04.004

    Article  PubMed  Google Scholar 

  24. Marconi L, Dabestani S, Lam TB, Hofmann F, Stewart F, Norrie J, Bex A, Bensalah K, Canfield SE, Hora M, Kuczyk MA, Merseburger AS, Mulders PFA, Powles T, Staehler M, Ljungberg B, Volpe A (2016) Systematic review and meta-analysis of diagnostic accuracy of percutaneous renal tumour biopsy. Eur Urol 69(4):660–673. https://doi.org/10.1016/j.eururo.2015.07.072

    Article  PubMed  Google Scholar 

  25. Pierorazio PM, Johnson MH, Patel HD, Sozio SM, Sharma R, Iyoha E, Bass EB, Allaf ME (2016) Management of renal masses and localized renal cancer: systematic review and meta-analysis. J Urol 196(4):989–999. https://doi.org/10.1016/j.juro.2016.04.081

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

For their assistance in providing clinical cases from electronic medical record systems, The authors gratefully acknowledge the following departments and fellows, the Pathologic Department (Liling Li), Xiangya Hospital; the Ultrasonic department (Ying Huang), Chongqing General Hospital; the Ultrasonic department (Shigen Zhong), Chongqing General Hospital; the Department of Geriatrics Surgery (Jingyu Zhou), The Second Xiangya Hospital, Central South University.

Funding

None.

Author information

Authors and Affiliations

Authors

Contributions

All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by YY, XL and YX. The first draft of the manuscript was written by WT and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Yi Yan.

Ethics declarations

Conflict of interest

The authors have no conflicts of interest to declare.

Ethics approval

This study was approved by the ethics committee of Chongqing general hospital. The procedures used in this study adhere to the tenets of the Declaration of Helsinki.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tong, W., Lin, X., Xu, Y. et al. The role of percutaneous fine needle aspiration biopsy in the management of small renal masses without chance of nephron-sparing surgery. Int Urol Nephrol 52, 2223–2228 (2020). https://doi.org/10.1007/s11255-020-02558-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-020-02558-z

Keywords

Navigation